Type of diabetes-Type 2 Posts on Medivizor
Navigation Menu

Type of diabetes-Type 2 Posts on Medivizor

Which insulin is better for reducing blood glucose levels before hypoglycemia occurs?

Posted by on Mar 28, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study compared two insulin types – degludec (Tresiba) and glargine (Lantus) – to see which was better at reducing blood glucose levels before hypoglycemia (dangerously low blood glucose levels) occurred. The study found that degludec improved blood glucose levels for longer than glargine before patients experienced...

Read More

Does dapagliflozin protect kidney function in patients with diabetes?

Posted by on Dec 30, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study looked at the effect of dapagliflozin (Farxiga) on kidney disease in patients with type 2 diabetes. It found patients treated with dapagliflozin were significantly less likely to have a decline in kidney function. Some background In type 2 diabetes (T2D), the body no longer regulates blood sugar well. If blood sugar is not...

Read More

Evaluating risk of low blood sugar in patients with diabetes taking insulin degludec

Posted by on Dec 25, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the safety and effectiveness of switching to insulin degludec (Tresiba) in patients with diabetes mellitus. This study concluded that patients had better blood glucose control and a lower risk of low blood sugar after switching. Some background Insulin therapy is the typical first-line treatment for patients...

Read More

Can dapagliflozin help improve blood magnesium levels in patients with Type 2 diabetes?

Posted by on Nov 6, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study examined the effects of dapagliflozin (Forxiga) on blood magnesium levels in patients with type 2 diabetes (T2D). The authors concluded that dapagliflozin treatment helped improve blood magnesium levels in these patients. Some background T2D is associated with a number of other health complications. Patients with T2D...

Read More

Can dapagliflozin with or without saxagliptin improve symptoms of kidney disease in patients with type 2 diabetes?

Posted by on Oct 5, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study examined if dapagliflozin (Farxiga) and saxagliptin (Onglyza) improved symptoms of kidney disease in patients with type 2 diabetes and kidney disease. The authors concluded that dapagliflozin with or without saxagliptin reduced kidney disease symptoms and lowered blood glucose levels in these patients. Some background...

Read More

Evaluating symptoms of anxiety and depression in patients with diabetes mellitus

Posted by on Aug 25, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study investigated how common symptoms of anxiety and depression are amongst patients with diabetes mellitus. This study concluded that 1 in 10 patients had symptoms of both anxiety and depression. Some background Depression is nearly twice as common in adults with diabetes compared to the general population. Approximately 1 in 5...

Read More

Can succinate levels in the blood indicate remission of Type 2 diabetes?

Posted by on Aug 25, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study examined if the levels of succinate in the blood could indicate remission of Type 2 diabetes (T2D) in patients that had bariatric surgery. The authors found that succinate levels were lower in patients who achieved remission of T2D after surgery. Some background One of the main goals of treatment for T2D is to lower...

Read More

Can linagliptin improve glucose control in older people with type 2 diabetes?

Posted by on Aug 18, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study examined if linagliptin (Tradjenta) was safer and more effective in older patients with Type 2 diabetes compared to a placebo. This study concluded that linagliptin helped improve glucose control for these patients without causing additional side effects. Some background About 90% of diabetes cases are of Type 2 diabetes...

Read More

Looking for patients with type 2 diabetes and high cholesterol to test a cholesterol-reducing drug combination

Posted by on Aug 14, 2019 in Diabetes mellitus | 0 comments

In a nutshell This trial is examining how effective the drug bempedoic acid is when used with ezetimibe (Zetia) to reduce cholesterol in patients with type 2 diabetes (T2D). The main outcome will be the measurement of patient’s cholesterol as well as heart disease risk, diabetes severity and drug side effects. This study is recruiting in...

Read More

Assessment of new predictors of kidney disease in patients with type 2 diabetes

Posted by on Aug 10, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the accuracy of four new predictors of kidney damage and disease are compared to the standard test for patients with Type 2 diabetes (T2D). The authors found that these new predictors were as accurate as the standard test at detecting kidney disease. Some background Many patients with Type 2 diabetes (T2D)...

Read More

SGLT-2 inhibitors and lower limb amputation risk in people with type 2 diabetes

Posted by on Jul 29, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study wanted to find out if treating type 2 diabetes with SGLT-2 inhibitors increases the risk of disease in blood vessels or the risk of amputation of the feet. The study found that treating type 2 diabetes with certain SGLT-2 inhibitors such as canagliflozin (Invokana) may be associated with an increased risk of disease in the...

Read More